Showing results (211-220 of 225) with videos related to
Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group StudyR J Packer, J Goldwein, H S Nicholson, et al.Neuroreport|March 27, 1999
Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitroJ Saura, L Curatolo, C E Williams, et al.Cancer Chemotherapy and Pharmacology|November 17, 2001
Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumorsK E Warren, M C Patel, A A Aikin, et al.Journal of Neurosurgery|July 1, 1998
Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945J H Wisoff, J M Boyett, M S Berger, et al.Bone Marrow Transplantation|August 5, 2000
High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumorsV Papadakis, I J Dunkel, L D Cramer, et al.Neurology|January 12, 2007
NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weightE Dombi, J Solomon, A J Gillespie, et al.Cancer|May 15, 1996
Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II studyR J Packer, M Prados, P Phillips, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer GroupJ L Finlay, S Goldman, M C Wong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor controlR J Packer, J M Boyett, A J Janss, et al.Cancer|August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumorsS M Blaney, P C Phillips, R J Packer, et al.Pageof 23